Specifically, ADAM17 is known to have a major role in activating most ligands of EGFR, such as amphiregulin, heparin-binding epidermal growth factor and epigen, representing a crucial pathway for tumor progression [12]. This evidence concerns the gene EGFR and neoplasm.